Navigation Links
Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US
Date:11/23/2009

Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007. Treatment rates appear to be declining, in part because only half of the patients know they are infected. If this disturbing trend continues, by 2030 less than 15% of liver-related deaths from HCV will be prevented by antiviral therapy. This study, the first to analyze nationwide practice patterns for HCV treatment, is published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

HCV is a common blood-borne infection that slowly damages the liver by causing inflammation of liver tissue, which can lead to cirrhosis, chronic liver disease, and liver cancer. In the U.S., HCV is a major public health burden and the leading cause of liver transplantation. According to the Centers for Disease Control and Prevention (CDC) 8,000-12,000 deaths occur each year due to HCV. While the incidence of new infections has declined, past studies point to a twofold to fourfold increase in death over the next 20 years due to widespread cases with longstanding infection.

Michael Volk, M.D., M.Sc., and colleagues obtained data of new patient prescriptions for pegylated interferon alpha-2a and -2b, sold under the brand names Pegasys and Peg Intron, respectively, and filled between 2002- 2007. Results of the prescription audit showed there were 126,000 new prescriptions for pegylated interferon products in 2002 and by 2007 that figured declined to 83,000 prescriptions. Researchers project fewer than 1.4 million patients would be treated cumulatively with antiviral medication by 2030 if the downward trend continued.

To further understand the decrease in antiviral therapy, researchers investigated treatment decisions using data from the National Health and Nutrition Evaluation Survey (NHANES
'/>"/>

Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections
2. New Asia Pacific Statistics Reveal an Alarming Incidence of HIV in MSM
3. Astronauts on International Space Station lose alarming amounts of hipbone strength
4. Alarming new data shows TB-HIV co-infection a bigger threat
5. Alarming Rise in Autism Brings Hundreds of Parents, Researchers and Clinicians Together from Around the World to Atlanta April 17-19, 2009
6. Report Finds an Alarming Number of Chronically Ill Patients - Over 93 Percent - Reporting Medical Debt Crisis Issues in 2008 Have Some Form of Insurance
7. Latinos in Chicago and Suburbs Face Alarming Numbers of Cases of Alzheimers Disease While Thousands More are at Risk of Being Diagnosed
8. HDNet World Report Investigates an Alarming String of Murders Committed by Iraq War Veterans
9. Susan G. Komen for the Cure(R), San Diego Releases Community Profile Unveiling Alarming Statistics About Breast Cancer in San Diego County
10. Diabetics show alarming increase in morbid obesity
11. Segal Survey Predicts Declines in Trends for Fifth Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 By studying one of the most ... set of successful strategies in his article What We ... Case Study. , The inspirational brand Gollan refers to ... had an impressive 62 million followers (and rising). , ... Top Facebook Pages earlier this year. The Facebook data tracking ...
(Date:6/18/2013)... cells in the mammary gland appear to provide a ... in life, and the subsequent development of breast cancer, ... July 2013 issue of the journal Cancer Prevention ... be associated with an increased risk of certain types ... biology of social stress to cancer have been hard ...
(Date:6/18/2013)... Physicians at University Hospitals Case Medical Center enrolled their ... clinical trial evaluating a novel, less-invasive procedure to help ... , Every year, more than 300,000 people in the ... their carotid artery. If left untreated, these blockages can ... causing a potentially disabling stroke, also known as a ...
(Date:6/18/2013)... Daniel Perlman has discovered a way to make phytosterol ... are consumed by humans, potentially opening the way to ... patent (#8,460,738) on the new process and composition was ... plants and cholesterol molecules in animals are highly similar ... to one another. When they mix in the gut ...
(Date:6/18/2013)... An international team of investigators co-led by Weill Cornell ... surgery and device research, similar to the kind of ... "Currently, there is no dynamic research framework to systematically ... to patients or may even be harmful," says co-lead ... , In the June 18 issue of the ...
Breaking Medicine News(10 mins):Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2Health News:Brandeis scientist invents anti-cholesterol process 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
... Denise Mann HealthDay Reporter , MONDAY, March 5 ... of premenstrual syndrome known as premenstrual dysphoric disorder (PMDD) were ... Now, new research suggests that these symptoms, which can ... and can linger through the first three days of menses ...
... COLUMBUS, Ohio Middle- and high-school students who bully their ... as cigarettes, alcohol and marijuana, a new study found. ... both perpetrators and victims were more likely to use ... suggest that one deviant behavior may be related to another," ...
... French . Montreal, March 5, 2012 Would ... honed his skills on a backyard rink as a kid? It,s ... wreaking havoc with our weather because the days of a game ... of Canada,s outdoor skating season has decreased significantly, according to findings ...
... (HealthDay News) -- Children with asthma have a higher risk ... infection with the herpes zoster virus, new research reveals. ... be infected with the herpes zoster virus every year. However, ... the age of 60 or people with weakened immune systems. ...
... News) -- Vitamin E may stimulate cells that result ... led by Shu Takeda of Keio University in Tokyo ... take vitamin E supplements. The researchers explain that ... cells (osteoclasts) keeps bones strong. Although prior studies had ...
... March 5 (HealthDay News) -- Whole-body CT scans ... injuries, but these tests could miss other serious problems ... The German researchers concluded that most emergency-room CT scans ... injuries. For the best results, the study authors concluded, ...
Cached Medicine News:Health News:Severe PMS May Last Longer Than Thought 2Health News:Severe PMS May Last Longer Than Thought 3Health News:School bullies more likely to be substance users, study finds 2Health News:School bullies more likely to be substance users, study finds 3Health News:Pond hockey heats up 2Health News:Children With Asthma at Higher Risk for Shingles: Study 2Health News:Mouse Study Suggests Vitamin E May Weaken Bones 2Health News:Whole-Body CT Scans Can Miss Traumatic Injuries: Study 2
(Date:6/18/2013)... , June 18, 2013 Today, Wall ... (NASDAQ: GILD ), Health Management Associates Inc. (NYSE: ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), ... these reports free of charge - including full price targets, ... Gilead Sciences, Inc. Research Report On ...
(Date:6/18/2013)... N.J. , June 18, 2013  Pro football ... Peterson and professional family expert Jo Frost ... with Mylan Specialty L.P., the fully integrated specialty pharmaceutical ... to raise awareness of this significant health problem. In ... U.S. Food and Drug Administration (FDA) approval of EpiPen ...
(Date:6/17/2013)... 2013  Hanger, Inc. (NYSE:  HGR) today announced the ... its senior secured facilities to an aggregate of up ... credit agreement includes a $200 million revolving credit facility ... credit agreement was comprised of a $100 million revolving ... new facility matures on June 17, 2018, and is ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3
... The Public Patent,Foundation ("PUBPAT") announced today that the ... drug patents held by Gilead Sciences,that relate to the ... weapon in the battle against HIV/AIDS. Gilead markets TDF ... as a part of its ATRIPLA,combination product., Roughly ...
... to be Conducted in Canada, ROCKVILLE, Md., ... a clinical-stage pharmaceutical company developing,therapeutics for the treatment ... of a Phase 2 study with its novel ... ovarian cancer and,advanced endometrial cancer patients. The study ...
Cached Medicine Technology:U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims 2EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers 2EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers 3EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers 4
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
Smooth, contoured visual obturator provides less traumatic insertion through the urethra and into the bladder....
... The URF-P3 features a tip ... minimal invasiveness, an up/down angulation range ... to previously hard-to-reach areas.,For improved observation, ... designed, and a reusable 11.7Fr (3.9mm) ...
... combines efficient stone fragmentation, low purchase price, ... clear LED display, automatic probe sensing circuitry, ... probe size. In addition, the AEH-4 has ... can also regulate and control relative power ...
Medicine Products: